Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OTLK | SPRO | CGTX | ||
| Company | Outlook Therapeutics Inc | Spero Therapeutics Inc | Cognition Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.0000 | 2.29 | 1.4000 | ||
| High | 2.0300 | 2.30 | 1.4150 | ||
| Low | 1.8200 | 2.27 | 1.3700 | ||
| Latest | 1.8650 | 2.27 | 1.3700 | ||
| Change | -0.1150 | -0.03 | -0.0400 | ||
| % Change | -5.81% | -1.30% | -2.84% | ||
| Volume | 6,171,000 | 195,500 | 740,900 | ||
| 20-Day Average Volume | 3,633,050 | 273,210 | 933,460 | ||
| Previous Close | 1.9800 | 2.30 | 1.4100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.0122 | 2.30 | 1.5815 | ||
| 20-Day Raw Stochastic | 21.57% | 37.50% | 0.00% | ||
| 20-Day Relative Strength | 51.15 | 47.26 | 42.39 | ||
| Weighted Alpha | +129.07 | -22.33 | -24.37 | ||
| Today's Opinion | 64% Buy | 24% Buy | 8% Sell | ||
| Previous Opinion | 64% Buy | 32% Buy | 8% Sell | ||
| Last Month's Opinion | 24% Buy | 80% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.36% since 12/22/25 | -4.22% since 12/22/25 | -13.84% since 12/22/25 | ||
| Low | 1.7700 on 12/24/25 | 2.27 on 12/30/25 | 1.3700 on 12/30/25 | ||
| High | 2.0300 on 12/30/25 | 2.41 on 12/23/25 | 1.6100 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | +4.19% since 11/28/25 | -5.42% since 11/28/25 | -21.26% since 11/28/25 | ||
| Low | 1.6800 on 12/22/25 | 2.18 on 12/03/25 | 1.3700 on 12/30/25 | ||
| High | 2.5375 on 12/17/25 | 2.42 on 12/19/25 | 1.8100 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +75.94% since 09/30/25 | +20.74% since 09/30/25 | +1.48% since 09/30/25 | ||
| Low | 1.0400 on 10/06/25 | 1.89 on 10/01/25 | 1.3014 on 11/21/25 | ||
| High | 2.5375 on 12/17/25 | 2.75 on 11/12/25 | 2.0500 on 10/10/25 | ||
| 6-Month | |||||
| %Chg | +16.56% since 06/30/25 | -21.72% since 06/30/25 | +342.22% since 06/30/25 | ||
| Low | 0.7900 on 08/28/25 | 1.80 on 08/20/25 | 0.2933 on 07/01/25 | ||
| High | 3.3900 on 08/26/25 | 3.22 on 07/09/25 | 3.8300 on 08/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 126,946 | 129,580 | 124,466 | ||
| Shares Outstanding, K | 64,114 | 56,339 | 88,274 | ||
| Annual Sales | 1,410,000 | 47,980,000 | 0 | ||
| Annual Net Income | -62,420,000 | -68,570,000 | -33,970,000 | ||
| Last Quarter Sales | 1,510,000 | 5,440,000 | 0 | ||
| Last Quarter Net Income | -20,150,000 | -7,380,000 | -4,930,000 | ||
| 60-Month Beta | 0.17 | 1.48 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 12/19/25 | -0.13 on 11/13/25 | -0.06 on 11/06/25 | ||
| Latest Earnings Date | 02/13/26 | 03/26/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 09/16/15 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||